Comparing younger vs older stem cell donors
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at whether getting stem cells from a younger donor works better than from an older donor for people having their first stem cell transplant to treat blood cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer or similar blood disorder.
- This is your first stem cell transplant.
- Your donor's stem cells match yours at least halfway.
- Your donor's age is known.
- You have follow-up health records available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a special health evaluation designed for older adults can help doctors better plan stem cell transplants for people 55 and older with blood disorders. You would receive a series of questionnaires and tests to assess your overall health before transplant.
This study compares a newer type of stem cell transplant (using special cells) to the standard method for children who need a half-matched donor. It aims to see if the new approach is safer and works as well.
This study compares outcomes in patients receiving stem cell transplants from either a sibling or a cousin donor. It looks at the transplant process to help doctors understand which type of donor might lead to better results for people with blood cancers.
This study tests two ways to prepare donated blood cells for children who need a stem cell transplant but don't have a perfectly matched sibling donor. The aim is to reduce side effects and improve outcomes.
This trial studies a special donor stem cell transplant where the donor’s immune cells are reduced, aiming to lower harmful immune attacks after transplant. It may help children and young adults with certain high-risk blood cancers or rare bone marrow disorders.
This study looks at what factors might affect whether people who need a donor stem cell transplant actually get one. It aims to help make sure everyone has a fair chance to receive this treatment.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.